道富環球:盈富基金(02800.HK)明日起恢復投資受制裁股份
道富環球投資管理亞洲有限公司表示,作為盈富基金(02800.HK)之經理人,盈富基金自今年1月14日起將恢復對屬於恆生指數成份股公司的受制裁實體進行投資。
道富環球表示,自從美國於2021年1月6日發佈更新的制裁名單以來,道富環球投資管理亞洲有限公司作為盈富基金之基金經理,一直努力檢閱若干事項,以繼續投資於所有恆生指數成份股。道富環球投資管理亞洲有限公司將如招股書所述,繼續努力實現盈富基金的投資目標,提供緊貼恆生指數表現的投資回報。鑑於盈富基金對香港市場的重要性,公司理解此事關乎重大公眾利益,並希望恢復投資一舉能證明公司如過去21年般,始終致力恪守盈富基金緊貼恆生指數表現的承諾。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.